Earnings call transcript: SNDL Inc reports Q2 2025 earnings beat with positive EPS surprise

SNDL Inc. reported a significant beat in Q2 2025, posting an unexpected earnings per share of $0.01 against a forecasted loss and revenue of $244.8 million, exceeding estimates. This performance, marked by the company's first-ever positive adjusted operating income of $5.8 million and 7.3% year-over-year revenue growth, fueled a 14.58% pre-market stock surge. The improved results stem from strong cannabis retail performance, strategic acquisitions, and cost management, though free cash flow remained negative due to working capital investments for international expansion. SNDL anticipates continued international sales growth and is cautiously evaluating U.S. market opportunities.

Analysis

SNDL Inc. delivered a pivotal second quarter in 2025, marked by a significant operational turnaround and its first-ever positive adjusted operating income of $5.8 million. The company reported an unexpected earnings per share of $0.01, decisively beating the forecasted loss of $0.05, on revenues of $244.8 million which grew 7.3% year-over-year. This performance was broad-based, with the Cannabis Operations segment growing revenue by 43% and Cannabis Retail by 11%, both outpacing the broader Canadian market. The Liquor Retail segment also returned to modest 1% growth, challenging narratives of secular decline. This top-line strength was complemented by disciplined cost management, evidenced by a $5 million year-over-year reduction in overhead expenses. Despite these P&L gains, free cash flow was negative at $7.9 million, a metric the company attributes to working capital investments for international expansion and seasonal payments. The company's strong balance sheet, with over $200 million in unrestricted cash and no debt, provides substantial strategic flexibility. However, the outlook for U.S. market entry remains constrained by legal and restructuring delays concerning its credit-held assets, with management explicitly stating they cannot currently influence operations due to listing rules. The stock's 14.58% pre-market surge and high beta of 3.57 underscore both positive market reception and inherent volatility.

Key Decisions for Investors

• Investors should recognize the Q2 results as a significant inflection point, where the achievement of positive operating income and a strong earnings beat may justify a fundamental re-rating of the stock, shifting focus from a speculative play to a turnaround and growth story.
• It is crucial to monitor free cash flow in the upcoming quarters to validate management's assertion that the current negative FCF is a temporary result of growth investments, as sustained cash burn would undermine the positive earnings narrative.
• While the U.S. market represents a long-term catalyst, near-term valuation should be primarily anchored to the performance of Canadian operations and nascent international sales, given the significant uncertainty and elongated timelines associated with consolidating U.S. assets.
• Given the stock's high beta of 3.57 and sharp price movements on news, positions should be managed with an awareness of heightened volatility, and investors might consider using price strength to rebalance exposure.